ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests

February 20, 1976

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Frist Backs Federal Funding For Stem Cell Research.

July 20, 2001

In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block

March 18, 1977

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Diabetes Associated With Greater Risk Of Cancer

December 28, 2007